Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Ratjen

Showing results (201-210 of 326) with videos related to

Pageof 33
Sort By:
Pediatric Pulmonology|February 29, 2008
Reliability and validity of the habitual activity estimation scale (HAES) in patients with cystic fibrosisGreg D Wells, Donna L Wilkes, Jane Schneiderman-Walker, et al.
Pediatric Pulmonology|July 10, 2008
Rapid pulmonary delivery of inhaled tobramycin for Pseudomonas infection in cystic fibrosis: a pilot projectAllan L Coates, Maria Green, Kitty Leung, et al.
American Journal of Respiratory and Critical Care Medicine|October 31, 2002
Endothelial nitric oxide synthase variants in cystic fibrosis lung diseaseHartmut Grasemann, Karin Storm van's Gravesande, Rainer Buscher, et al.
Academic Radiology|August 7, 2023
Semiautomated Segmentation and Analysis of Airway Lumen in Pediatric Patients Using Ultra Short Echo Time MRIDaniel Genkin, Brandon Zanette, Patrick Grzela, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 7, 2017
Pilot trial of tobramycin inhalation powder in cystic fibrosis patients with chronic Burkholderia cepacia complex infectionValerie Waters, Yvonne Yau, Trevor Beaudoin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 31, 2015
Tiotropium Respimat in cystic fibrosis: Phase 3 and Pooled phase 2/3 randomized trialsFelix Ratjen, Paul Koker, David E Geller, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 26, 2023
Cost-effectiveness analysis of genetic tools to predict treatment response in patients with cystic fibrosisYeva Sahakyan, Lusine Abrahamyan, Felix Ratjen, et al.
American Journal of Respiratory and Critical Care Medicine|February 1, 2011
Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with cystic fibrosisHartmut Grasemann, Suhail Al-Saleh, Jeremy A Scott, et al.
Nature Biotechnology|August 28, 2012
Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR proteinAmy P Wong, Christine E Bear, Stephanie Chin, et al.
The Journal of Antimicrobial Chemotherapy|April 21, 2007
Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patientsWallace Lam, James Tjon, Winnie Seto, et al.
Pageof 33

Showing results (201-210 of 326) with videos related to

Sort By:
Pageof 33
Pediatric Pulmonology|February 29, 2008
Reliability and validity of the habitual activity estimation scale (HAES) in patients with cystic fibrosisGreg D Wells, Donna L Wilkes, Jane Schneiderman-Walker, et al.
Pediatric Pulmonology|July 10, 2008
Rapid pulmonary delivery of inhaled tobramycin for Pseudomonas infection in cystic fibrosis: a pilot projectAllan L Coates, Maria Green, Kitty Leung, et al.
American Journal of Respiratory and Critical Care Medicine|October 31, 2002
Endothelial nitric oxide synthase variants in cystic fibrosis lung diseaseHartmut Grasemann, Karin Storm van's Gravesande, Rainer Buscher, et al.
Academic Radiology|August 7, 2023
Semiautomated Segmentation and Analysis of Airway Lumen in Pediatric Patients Using Ultra Short Echo Time MRIDaniel Genkin, Brandon Zanette, Patrick Grzela, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 7, 2017
Pilot trial of tobramycin inhalation powder in cystic fibrosis patients with chronic Burkholderia cepacia complex infectionValerie Waters, Yvonne Yau, Trevor Beaudoin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 31, 2015
Tiotropium Respimat in cystic fibrosis: Phase 3 and Pooled phase 2/3 randomized trialsFelix Ratjen, Paul Koker, David E Geller, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 26, 2023
Cost-effectiveness analysis of genetic tools to predict treatment response in patients with cystic fibrosisYeva Sahakyan, Lusine Abrahamyan, Felix Ratjen, et al.
American Journal of Respiratory and Critical Care Medicine|February 1, 2011
Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with cystic fibrosisHartmut Grasemann, Suhail Al-Saleh, Jeremy A Scott, et al.
Nature Biotechnology|August 28, 2012
Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR proteinAmy P Wong, Christine E Bear, Stephanie Chin, et al.
The Journal of Antimicrobial Chemotherapy|April 21, 2007
Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patientsWallace Lam, James Tjon, Winnie Seto, et al.
Pageof 33